PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
1-Year Est. Return 73.17%
This Quarter Est. Return
1 Year Est. Return
+73.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.67B
AUM Growth
-$155M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$166M
2
+$44.4M
3
+$37.5M
4
CAI
Caris Life Sciences
CAI
+$29.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$19.5M

Top Sells

1
+$104M
2
+$99.9M
3
+$90.2M
4
FOLD icon
Amicus Therapeutics
FOLD
+$80.5M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$42.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDSX icon
76
Biodesix
BDSX
$51.4M
$613K 0.02%
2,173,880
LXEO icon
77
Lexeo Therapeutics
LXEO
$517M
$562K 0.02%
139,835
APYX icon
78
Apyx Medical
APYX
$110M
$338K 0.01%
150,000
KALA icon
79
KALA BIO
KALA
$9.2M
$263K 0.01%
55,227
-222,383
ENSC icon
80
Ensysce Biosciences
ENSC
$7.06M
$193K 0.01%
86,666
RVMDW icon
81
Revolution Medicines Inc Warrant
RVMDW
$3.53M
$65.7K ﹤0.01%
250,000
SRZNW icon
82
Surrozen Inc Warrant
SRZNW
$36K
$3.02K ﹤0.01%
166,666
ACRV icon
83
Acrivon Therapeutics
ACRV
$56.9M
– –
-5,360,858
ADPT icon
84
Adaptive Biotechnologies
ADPT
$2.48B
– –
-930,972
APLT icon
85
Applied Therapeutics
APLT
$184M
– –
-860,000
ARGX icon
86
argenx
ARGX
$51.9B
– –
-59,510
CAPR icon
87
Capricor Therapeutics
CAPR
$286M
– –
0
CGEM icon
88
Cullinan Oncology
CGEM
$464M
– –
-80,100
CRGX
89
DELISTED
CARGO Therapeutics
CRGX
– –
-2,431,085
DCTH icon
90
Delcath Systems
DCTH
$419M
– –
-462,422
DXCM icon
91
DexCom
DXCM
$26.1B
– –
-178,000
EYPT icon
92
EyePoint Pharmaceuticals
EYPT
$811M
– –
-1,537,274
IOVA icon
93
Iovance Biotherapeutics
IOVA
$789M
– –
-12,711,788
IRON icon
94
Disc Medicine
IRON
$3.13B
– –
-150,000
MDGL icon
95
Madrigal Pharmaceuticals
MDGL
$9.78B
– –
-46,500
MREO
96
Mereo BioPharma
MREO
$326M
– –
-876,961
NBTX
97
Nanobiotix
NBTX
$1.23B
– –
-105,053
OCUL icon
98
Ocular Therapeutix
OCUL
$2.51B
– –
-915,775
PCVX icon
99
Vaxcyte
PCVX
$5.5B
– –
-706,567
RCKT icon
100
Rocket Pharmaceuticals
RCKT
$400M
– –
-140,726
1 2 3
4
5